- Home
- CLNN vs FMY Comparison
CLNN vs FMY Comparison
Compare CLNN & FMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLNN | FMY |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.4M | 49.0M |
| IPO Year | 2021 | 2005 |
Fundamental Metrics
Financial Performance| Metric | CLNN | FMY |
|---|---|---|
| Price | $4.36 | $11.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $33.75 | N/A |
| AVG Volume (30 Days) | ★ 119.0K | 3.0K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.98% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $200,000.00 | N/A |
| Revenue This Year | $17.64 | N/A |
| Revenue Next Year | $19,516.77 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.25 | $11.21 |
| 52 Week High | $13.50 | $12.36 |
Technical Indicators
Market Signals| Indicator | CLNN | FMY |
|---|---|---|
| Relative Strength Index (RSI) | 53.74 | 44.15 |
| Support Level | $3.92 | N/A |
| Resistance Level | $4.70 | $11.89 |
| Average True Range (ATR) | 0.38 | 0.20 |
| MACD | 0.09 | -0.01 |
| Stochastic Oscillator | 96.64 | 27.54 |
Price Performance
Historical ComparisonAbout CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
About FMY First Trust Motgage Income Fund of Beneficial Interest
First Trust Mortgage Income Fund is a United States-based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield, and maturity.